Bullous pemphigoid triggered by COVID-19 vaccine: Rapid resolution with corticosteroid therapy.

Dell'Antonia, Massimo; Anedda, Speranza; Usai, Federica; Atzori, Laura; Ferreli, Caterina

Dell'Antonia, Massimo; Anedda, Speranza; Usai, Federica; Atzori, Laura; Ferreli, Caterina.

Dell'Antonia M; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Anedda S; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Usai F; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Atzori L; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
Ferreli C; Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

Dermatol Ther ; 35(1): e15208, 2022 01.

Article in English | MEDLINE | ID: covidwho-1522686

Subject(s)

COVID-19; Pemphigoid, Bullous; COVID-19 Vaccines; Glucocorticoids; Humans; Pemphigoid, Bullous/chemically induced; Pemphigoid, Bullous/diagnosis; Pemphigoid, Bullous/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pemphigoid, Bullous / COVID-19 Type of study: Diagnostic study Topics: Vaccines Limits: Humans Language: English Journal: Dermatol Ther Journal subject: Dermatology Year: 2022 Document Type: Article Affiliation country: Dth.15208

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google